NEW YORK — Eli Lilly and Co. has downplayed for about 10 years the risks associated with Zyprexa, which treats schizophrenia, The New York Times said on its Web site Sunday, citing internal documents from the drug maker and e-mail messages of its managers.
The documents, obtained from a lawyer for mentally ill patients, show Lilly executives kept data from doctors about the drug’s tendencies to promote obesity and boost blood sugar, the newspaper said.
Zyprexa is Lilly’s best-selling product. With sales of $4.2 billion last year, about 2 million people worldwide were taking the drug.
Thirty percent of patients taking Zyprexa gain 22 pounds or more after a year on the drug, and some patients have reported putting on more than 100 pounds, according to information published by Lilly. But the internal documents, which cover the period from 1995 to 2004, show Lilly feared sales would be hurt if the company was open with doctors the drug’s side effects, the paper said.
If you didn’t read the summary: Zyprexa causes diabetes.
The Rest

ELI LILLY MAKES INSULIN.

A Fortune 500 corporation, Eli Lilly had revenues of $14.6 billion in 2005, making it the 148th largest company in the United States. The company is publicly traded on the New York Stock Exchange and is a member of the S&P 500 stock index. Sell Eli Lilly (above url).

I can’t stand it, every song is great. This is a repeat post. Buy this album. I can’t stop listening.
I will have to double check this, but I think Dir en grey is coming to orlando in February. If I had to recommend just one song I couldn’t but it just so happens you can WATCH the enormous fish-hooking action and download it to your hard disk (rip it here)